Skip to main content
U.S. Department of Health & Human Services
  • CSR Extranet
  • Staff Directory
  • Contact CSR
National Institutes of Health: Center for Scientific Review
  • For Applicants
  • For Reviewers
  • Study Sections
  • Review Meetings
  • Evaluation Initiatives
  • About CSR
  • CSR Employee Intranet
  • Staff Directory
  • Contact CSR
  • Application Process
  • Planning & Writing
  • Due Dates
  • Submission & Assignment
  • Initial Review, Results, & Appeals
  • Frequently Asked Questions (FAQs)

For Applicants

CSR’s primary role is to handle the receipt and review of all grant applications that NIH receives. NIH separates the review process from funding decisions.

  • Reviewer Recruitment
  • Reviewer Resources
  • Travel & Reimbursement
  • Frequently Asked Questions (FAQs)

For Reviewers

Reviewers are critical to our mission to see that NIH grant applications receive, fair, independent, expert, and timely scientific reviews. We appreciate the generosity with which reviewers give their time.

Study Sections

Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.

  • Review Branches
  • Standing Study Sections
  • Small Business & Technology Transfer
  • Fellowship
  • Special Emphasis
  • HIV/AIDS Research

Review Meetings

Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.

  • Search Panels
  • Search Meeting Dates
  • Meeting Overview
  • CSR Peer Review Webinars & Videos

Evaluation Initiatives

Access data visualizations, reports, and analytical tools to track progress.

  • CSR Data & Evaluations
  • Strengthening Peer Review
  • ENQUIRE Reviews

About CSR

  • CSR Mission
  • CSR Director
  • CSR Organization
  • Public Meetings - Materials
  • News & Updates
  • Strategic Plan

CSR SS Search

Study Section Description Scientific Review Officer
ZRG1 BP-K (94) Communication and Language Dr. Andrea Kelly
ZRG1 BP-U (92) Cognitive, Motor and Language Habilitation and Rehabilitation Dr. Abhignya Subedi
ZRG1 BTC-A (41) Program Projects: Translational Cancer Research SPORE P50 Dr. Amr Ghaleb
ZRG1 BTC-A (43) Program Projects: Translational Cancer Research SPORE P50 Dr. Amr Ghaleb
ZRG1 BTC-N (81) Basic and Translational Cancer Research Dr. Nadeem Khan
ZRG1 BTC-Y (81) Topics in Basic and Translational Cancer Research Dr. David Ransom
ZRG1 CCHI-K (57) PAR Panel: Mental Health and Alzheimer's Disease & Related Dementias (ADRD) Interventions and Outcomes Dr. Karin Garg
ZRG1 CCHI-N (02) Member Conflict: Clinical Care and Health interventions
ZRG1 CDB-V (90) Topics in Cellular Mechanisms of Aging and Development Dr. Mirela Milescu
ZRG1 CDD-Q (81) Cardiovascular Differentiation and Development Dr. Sara Ahlgren
ZRG1 CDPT-Z (02) Member Conflict: Cancer Prevention and Therapeutics Dr. Ola Mae Howard
ZRG1 CN-K (55) PAR Panel: Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Dr. Aleksey Kazantsev
ZRG1 CN-W (54) PAR's Panel: Rare Diseases Clinical Research Consortia Dr. Anita Tandle
ZRG1 CTH-H (50) PAR-23-242: NCI Research Specialist (Laboratory-based Scientist) Award (R50) Dr. Bruce Hissong
ZRG1 CTH-P (40) IDeA Clinical and Translational Research Development (CTR-D) Award (P20/P50) Dr. Michael Opata
ZRG1 CTH-V (81) Clinical and Translational Cancer Research Dr. Viktoriya Sidorenko
ZRG1 CTH-X (81) Clinical and Translational Cancer Research Dr. Shuli Xia
ZRG1 DCAI-D (02) Member Conflict: Topics in Infectious Diseases Dr. Dayadevi Jirage
ZRG1 DCAI-K (81) Infectious Disease Drug Development and Molecular Pharmacology Dr. Ekaterina Nestorovich
ZRG1 DCAI-S (40) RFA-25-035: Influenza Transmission Research Consortium Dr. Liangbiao Zheng
ZRG1 EMS-H (50) PAR-25-438: Rare Diseases Clinical Research Consortia for the Rare Diseases Clinical Research Network Dr. Latha Malaiyandi
ZRG1 EPH-L (50) PAR-25-438: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) Dr. Cynthia McOliver
ZRG1 EPH-T (02) Member Conflict: Clinical, Behavioral and Environmental Epidemiology, Special Emphasis Panel Dr. Gianina Dumitrescu
ZRG1 HSS-F (50) PAR Panel: Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations Dr. Shareen Iqbal
ZRG1 HSS-J (02) Member Conflict: Health Services: Quality and Effectiveness Dr. Michael McQuestion

Pagination

  • Previous page ‹‹
  • Next page ››

User account menu

 

  • Contact Us
  • X
  • YouTube
  • LinkedIn
  • More Social Media from NIH
National Institutes of Health: Center for Scientific Review National Institutes of Health: Center for Scientific Review
National Institutes of Health, Center for Scientific Review
6701 Rockledge Drive MSC 7768, Bethesda MD 20817
(301) 435-1111

Site Map

CSR Home

For Applicants

  • Application Process
  • Planning & Writing
  • Due Dates
  • Submission & Assignment
  • Initial Review, Results, & Appeals
  • Frequently Asked Questions (FAQs)

For Reviewers

  • Become a Reviewer
  • Reviewer Resources
  • Travel & Reimbursement
  • Frequently Asked Questions (FAQs)

Study Sections

  • Review Branches
  • Standing Study Sections
  • Small Business & Technology Transfer
  • Fellowship
  • Special Emphasis
  • HIV/AIDS Research

Review Meetings

  • Search Panels
  • Search Meeting Dates
  • Meeting Overview
  • CSR Peer Review Webinars & Videos

Evaluation Initiatives

  • CSR Data & Evaluations
  • Strengthening Peer Review
  • ENQUIRE Reviews

About CSR

  • CSR Mission
  • CSR Director
  • CSR Organization
  • Public Meetings - Materials
  • News & Updates
  • Strategic Plan

Employment


United States Department of Health & Human Services United States Department of Health & Human Services
National Institutes of Health National Institutes of Health
USA.gov USA.gov

  • FOIA
  • Disclaimer & Privacy Statements
  • Accessibility Statements
  • HHS Vulnerability Disclosure